These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33030416)

  • 1. An analysis of totally implantable central venous port system infections in an urban tertiary referral center.
    Krümpelmann U; Boseila A; Löhnert M; Kaup O; Clarenbach JJ; Görner M
    J Chemother; 2021 Jul; 33(4):228-237. PubMed ID: 33030416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Lock Therapy in the Era of Gram-Negative Resistance.
    Soman R; Gupta N; Suthar M; Kothari J; Almeida A; Shetty A; Rodrigues C
    J Assoc Physicians India; 2016 Feb; 64(2):32-37. PubMed ID: 27730778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Venous Catheter-related Bloodstream Infections in Hospitalized Children: The Role of Gram-negative Bacteria.
    Berger I; Cohen T; Rahmani E; Levy I; Lowenthal A; Levinsky Y; Goldberg L; Marcus N; Kropach N; Ben-Zvi H; Chodik G; Ashkenazi-Hoffnung L; Scheuerman O
    Pediatr Infect Dis J; 2021 Nov; 40(11):e395-e399. PubMed ID: 34232922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection.
    Zanwar S; Jain P; Gokarn A; Devadas SK; Punatar S; Khurana S; Bonda A; Pruthy R; Bhat V; Qureshi S; Khattry N
    Transpl Infect Dis; 2019 Feb; 21(1):e13017. PubMed ID: 30369006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
    Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
    J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous catheters and biofilms: where do we stand in 2017?
    Gominet M; Compain F; Beloin C; Lebeaux D
    APMIS; 2017 Apr; 125(4):365-375. PubMed ID: 28407421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.
    Freire MP; Pierrotti LC; Zerati AE; Benites L; da Motta-Leal Filho JM; Ibrahim KY; Araujo PH; Abdala E
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is antibiotic lock therapy effective for the implantable longterm catheter-related bloodstream infections in children?
    Kara TT; Özdemir H; Erat T; Yahşi A; Aysev AD; Taçyıldız N; Ünal E; İleri T; İnce E; Haskoloğlu Ş; Çiftçi E; İnce E
    Turk J Pediatr; 2019; 61(6):895-904. PubMed ID: 32134584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
    Chauhan A; Lebeaux D; Ghigo JM; Beloin C
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6310-8. PubMed ID: 23027191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter Salvage After Catheter-Related Bloodstream Infection During Home Parenteral Nutrition.
    Edakkanambeth Varayil J; Whitaker JA; Okano A; Carnell JJ; Davidson JB; Enzler MJ; Kelly DG; Mundi MS; Hurt RT
    JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):481-488. PubMed ID: 25972432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome.
    Santarpia L; Buonomo A; Pagano MC; Alfonsi L; Foggia M; Mottola M; Marinosci GZ; Contaldo F; Pasanisi F
    Clin Nutr; 2016 Dec; 35(6):1394-1398. PubMed ID: 27068496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections.
    Chaftari AM; Hachem R; Raad S; Jiang Y; Natividad E; Chaftari P; Raad I
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):222-225. PubMed ID: 29331162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis.
    Yen HW; Yang WC; Tarng DC; Yang CY; Chuang CL; Huang LJ; Lin PY; Wang CC; Li SY
    Hemodial Int; 2016 Apr; 20(2):315-20. PubMed ID: 26549513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port.
    Iida Y; Hongo K; Onoda T; Kita Y; Ishihara Y; Takabayashi N; Kobayashi R; Hiramatsu T
    Sci Rep; 2021 Mar; 11(1):5385. PubMed ID: 33686152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed?
    Hebeisen UP; Atkinson A; Marschall J; Buetti N
    Antimicrob Resist Infect Control; 2019; 8():21. PubMed ID: 30719282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection.
    Lee GJ; Hong SH; Roh SY; Park SR; Lee MA; Chun HG; Hong YS; Kang JH; Kim SI; Kim YJ; Chun HJ; Oh JS
    Cancer Res Treat; 2014 Jul; 46(3):250-60. PubMed ID: 25038760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
    Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
    J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.